Unity Biotechnology, Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On April 3, 2025, Paul L. Berns informed the Board of Directors (the “Board”) of UNITY Biotechnology, Inc. (“Unity” or the “Company”) of his resignation as a member of the Board of the Company, and all of the committees of the Board on which he serves, in each case, effective at the close of business on April 4, 2025.
Extracted from this filing and checked against the source text.
Paul L. Berns resigned as Director at Unity Biotechnology, Inc..
On April 3, 2025, Paul L. Berns informed the Board of Directors (the “Board”) of UNITY Biotechnology, Inc. (“Unity” or the “Company”) of his resignation as a member of the Board of the Company, and all of the committees of the Board on which he serves, in each case, effective at the close of business on April 4, 2025.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.